Calamos Advisors »

Protagonist Therapeutics shares owned by Calamos Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 24k 105.40

More positions owned by Calamos Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Western Digital Corp Note 3.000%11/1 (Principal)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
UBS Group
Rtw Investments
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Henderson Group
Johnson & Johnson
Invesco
Geode Capital Management
Citadel Advisors
Woodline Partners
Bank of America Corporation

View all funds holding Protagonist Therapeutics